Hammond J R, Johnstone R M
Department of Biochemistry, McGill University, Montreal, Canada.
Biochem J. 1989 Aug 15;262(1):109-18. doi: 10.1042/bj2620109.
Uptake of [3H]uridine by Ehrlich cells was mediated by both nitrobenzylthioinosine (NBMPR)-sensitive (75%) and NBMPR-insensitive (25%) mechanisms. Each cell contained approx. 26,000 high-affinity (KD = 0.19 nM) recognition sites for [3H]NBMPR, and binding was inhibited by dipyridamole and adenosine at concentrations similar to those required for inhibition of [3H]uridine uptake. Calculations show that each cell contains a total of about 35,000 nucleoside transporters. Photoaffinity labelling of a partially purified preparation of plasma membranes with [3H]NBMPR resulted in a single broad 3H-labelled band on SDS/polyacrylamide gels, with an apparent molecular-mass peak of 42 kDa. This is in contrast with human erythrocyte membranes, where [3H]NBMPR photolabelled two broad bands with peaks at 55 and 80 kDa. Treatment of photoaffinity-labelled membranes with endoglycosidase F decreased the apparent molecular masses of both the Ehrlich-cell and erythrocyte [3H]NBMPR-labelled proteins to approx. 40 kDa. These results suggest that the human erythrocyte [3H]NBMPR-binding polypeptides are more extensively glycosylated than the corresponding Ehrlich-cell polypeptides. Octyl beta-D-glucopyranoside [1.0% (w/v) + asolectin] solubilized over 90% of the [3H]NBMPR-binding sites, with near-complete retention of [3H]NBMPR-binding characteristics. The only major change was a 65-fold decrease in affinity for dipyridamole, which was partly reversed upon incorporation of the solubilized proteins into asolectin membranes. Proteoliposomes, prepared by using asolectin and the octyl glucoside-solubilized plasma membranes, were capable of accumulating [3H]uridine via a protein-dependent dipyridamole/nitrobenzylthioguanosine/dilazep-sensitive mechanism. We have thus demonstrated the efficient solubilization and functional reconstitution of a nucleoside-transport system from Ehrlich ascites-tumour cells.
艾氏腹水癌细胞对[3H]尿苷的摄取是由对硝基苄硫基肌苷(NBMPR)敏感(75%)和不敏感(25%)的机制介导的。每个细胞大约含有26,000个对[3H]NBMPR的高亲和力(KD = 0.19 nM)识别位点,双嘧达莫和腺苷在抑制[3H]尿苷摄取所需的相似浓度下可抑制其结合。计算表明,每个细胞总共含有约35,000个核苷转运体。用[3H]NBMPR对部分纯化的质膜制剂进行光亲和标记,在SDS/聚丙烯酰胺凝胶上产生了一条单一的宽3H标记带,表观分子量峰值为42 kDa。这与人类红细胞膜形成对比,在人类红细胞膜中,[3H]NBMPR光标记出两条宽带,峰值分别在55和80 kDa。用内切糖苷酶F处理光亲和标记的膜,可使艾氏腹水癌细胞和红细胞的[3H]NBMPR标记蛋白的表观分子量降至约40 kDa。这些结果表明,人类红细胞的[3H]NBMPR结合多肽比相应的艾氏腹水癌细胞多肽糖基化程度更高。辛基β-D-吡喃葡萄糖苷[1.0%(w/v)+大豆卵磷脂]可溶解超过90%的[3H]NBMPR结合位点,[3H]NBMPR结合特性几乎完全保留。唯一的主要变化是对双嘧达莫的亲和力下降了65倍,将溶解的蛋白质掺入大豆卵磷脂膜后,这种下降部分得到逆转。通过使用大豆卵磷脂和辛基葡萄糖苷溶解的质膜制备的蛋白脂质体,能够通过一种依赖蛋白质的、对双嘧达莫/硝基苄硫基鸟苷/地拉卓敏感的机制积累[3H]尿苷。因此,我们证明了从艾氏腹水癌细胞中高效溶解和功能性重建核苷转运系统。